Global Health Watch 1 in one file
Global Health Watch 1 in one file Global Health Watch 1 in one file
table a1 Key health concerns with WTO agreements Agreement Health impacts from loss of domestic regulatory space Agreement on Trade Related Intellectual Limited access to essential medicines. Higher cost of drugs drains money useful for primary Property Rights health care. Agreement on Sanitary and Phytosanitary Requires scientific risk assessments even when foreign goods treated no differently than Measures domestic goods (i.e. there is no discrimination). Such assessments are costly and imperfect with many health risks associated with environmental and manufactured products. Technical Barriers to Trade Agreement Requires that any regulatory barrier to the free flow of goods be as ‘least trade restrictive as possible’. Many trade disputes over domestic health and safety regulations have invoked this agreement. To date only one dispute favoured the exception allowing countries to abrogate from rules to protect health (France’s ban on the import of Canadian asbestos products). Agreement on Trade Related Investment Limits countries’ abilities to direct investment where it would do most good for domestic Measures economic development and employment equity, both important to population health. Agreement on Government Procurement Limits government’s abilities to use its contracts or purchases for domestic economic development, regional equity, employment equity or other social goals with strong links to better population health. Agreement on Agriculture Continuing export and producer subsidies by the USA, EU, Japan and Canada depress world prices and cost developing countries hundreds of millions of dollars in lost revenue which could fund health-promoting services. Subsidized food imports from wealthy countries undermine domestic growers’ livelihoods. Market barriers to food products from developing countries persist and deny them trade-related earnings. General Agreement on Trade in Services Locks in and could increase private provision of key health-promoting services, reducing equitable access by poorer families and groups.
environment affairs even if they treat products from other countries no differently than their own (Drache et al. 2002). The Agreement on Trade-Related Investment Measures (TRIMS) prevents countries from attaching performance requirements (such as minimum levels of local content) to approvals of foreign investment. Such requirements have proved useful in the development of a viable domestic economy, partly by ensuring health-promoting employment and income adequacy for marginalized groups or regions. Their removal benefits investors from high-income countries much more than people in low- and middle-income nations (Greenfield 2001). Similarly the Agreement on Government Procurement (AGP) requires governments to take into account only ‘commercial considerations’ when making purchasing decisions, precluding preferences based on environment, human or labour rights. Although this is a voluntary agreement that few low- or middle-income countries have signed, high-income countries are intent on making it mandatory and binding on all WTO members as part of their agenda for the Doha round of negotiations, begun in 2001. The Agreement on Agriculture was designed to increase global trade in agricultural goods by reducing tariffs and phasing out export subsidies (financial assistance for food exports) and production subsidies (financial assistance for farmers). During a ten-year moratorium on trade challenges under this agreement that ended in 2004, many high-income countries failed to reduce their tariffs on agricultural products (World Bank/IMF 2002) and retained both tariff peaks (a higher-than-average import tax) on raw food imports and tariff escalations on finished food products (where more money can be made), taxing them at 2–3 times the rate of raw food imports (Watkins 2002). Highincome countries also continued to pay huge subsidies to their domestic agricultural producers. Failure to reach an agreement on subsidy removal was the main reason for the collapse of the Cancún WTO ministerial talks in 2003. A 2004 WTO framework agreement to begin phasing out subsidies may remedy this impasse, but details are still subject to negotiation and the US says it will not begin to negotiate such reductions until after developing countries lower their agricultural tariffs (ICTSD 2004a). Incredibly, the 2004 agreement allows the US to retain a US$ 180 billion increase in domestic farm subsidies announced in 2002, as long as it can show they do not affect current levels of agricultural production (ICTSD 2004b). The Agreement on Trade-Related Intellectual Property Rights (TRIPS) is unlike other WTO agreements in that it does not ‘free’ trade, but protects intellectual property rights, mostly held by companies or individuals in rich countries. Health for all in a ‘borderless world’? 33
- Page 1 and 2: About this book Today’s global he
- Page 3 and 4: Global Health Watch 2005-2006 An al
- Page 5 and 6: Contents Boxes, figures and tables
- Page 7 and 8: C2.1 The facts about disability 180
- Page 9 and 10: Illustrations 1 Medicine cannot dea
- Page 11 and 12: Acknowledgements The following indi
- Page 13 and 14: London School of Hygiene and Tropic
- Page 15 and 16: Victoria, Canada; Centre for Health
- Page 17 and 18: Foreword New reports on different a
- Page 19 and 20: Introduction Origins The Global Hea
- Page 21 and 22: Child malnutrition, death and disab
- Page 23 and 24: Human rights and responsibilities A
- Page 25 and 26: impacting on health. The Watch hope
- Page 27: part a | Health and globalization T
- Page 30 and 31: Health and globalization | A1 and h
- Page 32 and 33: Health and globalization | A1 in 20
- Page 34 and 35: Health and globalization | A1 is gl
- Page 36 and 37: Health and globalization | A1 peopl
- Page 38 and 39: Health and globalization | A1 numbe
- Page 40 and 41: Health and globalization | A1 and p
- Page 42 and 43: Health and globalization | A1 econo
- Page 44 and 45: Health and globalization | A1 Box A
- Page 46 and 47: Health and globalization | A1 half
- Page 48 and 49: Health and globalization | A1 appro
- Page 52 and 53: Health and globalization | A1 Healt
- Page 54 and 55: Health and globalization | A1 merci
- Page 56 and 57: Health and globalization | A1 thems
- Page 58 and 59: Health and globalization | A1 Even
- Page 60 and 61: Health and globalization | A1 • A
- Page 62 and 63: Health and globalization | A1 non-v
- Page 64 and 65: Health and globalization | A1 27-28
- Page 66 and 67: Health and globalization | A1 Jenki
- Page 68 and 69: Health and globalization | A1 Satte
- Page 70 and 71: Health and globalization | A1 WHO (
- Page 72 and 73: and regulatory authorities mandated
- Page 74 and 75: Health care systems | B1 4) selecti
- Page 76 and 77: Health care systems | B1 • And si
- Page 78 and 79: Health care systems | B1 • declin
- Page 80 and 81: Health care systems | B1 user charg
- Page 82 and 83: Health care systems | B1 focus on t
- Page 84 and 85: Health care systems | B1 for health
- Page 86 and 87: Health care systems | B1 their cont
- Page 88 and 89: Health care systems | B1 health car
- Page 90 and 91: Health care systems | B1 ing servic
- Page 92 and 93: Health care systems | B1 Box B1.7 G
- Page 94 and 95: Health care systems | B1 many of th
- Page 96 and 97: Health care systems | B1 the lack o
- Page 98 and 99: Macro-economic factors Impoverished
table a1 Key health concerns with WTO agreements<br />
Agreement <strong>Health</strong> impacts from loss of domestic regulatory space<br />
Agreement on Trade Related Intellectual Limited access to essential medic<strong>in</strong>es. Higher cost of drugs dra<strong>in</strong>s m<strong>one</strong>y useful for primary<br />
Property Rights health care.<br />
Agreement on Sanitary and Phytosanitary Requires scientific risk assessments even when foreign goods treated no differently than<br />
Measures domestic goods (i.e. there is no discrim<strong>in</strong>ation). Such assessments are costly and imperfect with<br />
many health risks associated with environmental and manufactured products.<br />
Technical Barriers to Trade Agreement Requires that any regulatory barrier to the free flow of goods be as ‘least trade restrictive as<br />
possible’. Many trade disputes over domestic health and safety regulations have <strong>in</strong>voked this<br />
agreement. To date only <strong>one</strong> dispute favoured the exception allow<strong>in</strong>g countries to abrogate from<br />
rules to protect health (France’s ban on the import of Canadian asbestos products).<br />
Agreement on Trade Related Investment Limits countries’ abilities to direct <strong>in</strong>vestment where it would do most good for domestic<br />
Measures economic development and employment equity, both important to population health.<br />
Agreement on Government Procurement Limits government’s abilities to use its contracts or purchases for domestic economic<br />
development, regional equity, employment equity or other social goals with strong l<strong>in</strong>ks to better<br />
population health.<br />
Agreement on Agriculture Cont<strong>in</strong>u<strong>in</strong>g export and producer subsidies by the USA, EU, Japan and Canada depress world<br />
prices and cost develop<strong>in</strong>g countries hundreds of millions of dollars <strong>in</strong> lost revenue which could<br />
fund health-promot<strong>in</strong>g services. Subsidized food imports from wealthy countries underm<strong>in</strong>e<br />
domestic growers’ livelihoods. Market barriers to food products from develop<strong>in</strong>g countries<br />
persist and deny them trade-related earn<strong>in</strong>gs.<br />
General Agreement on Trade <strong>in</strong> Services Locks <strong>in</strong> and could <strong>in</strong>crease private provision of key health-promot<strong>in</strong>g services, reduc<strong>in</strong>g<br />
equitable access by poorer families and groups.